Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-12-15 Purchase |
2023-12-19 6:30 pm |
Tarsus Pharmaceuticals Inc. | TARS | Goldberg Andrew D. Director |
1,000 | $18.96 | $18,960 | 3,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-07 Exercise |
2025-03-11 4:01 pm |
N/A 2032-06-15 |
Tarsus Pharmaceuticals Inc. | TARS | Goldberg Andrew D. Director |
7,000 | $0 | 13,350 (Direct) |
View |
| 2025-03-07 Exercise |
2025-03-11 4:01 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Goldberg Andrew D. Director |
7,000 | $12.89 | 13,350 (Direct) |
View |
| 2024-06-24 Exercise |
2024-06-25 6:26 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Goldberg Andrew D. Director |
3,350 | $0 | 6,350 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 5:45 pm |
N/A 2034-06-12 |
Tarsus Pharmaceuticals Inc. | TARS | Goldberg Andrew D. Director |
8,350 | $0 | 8,350 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 5:56 pm |
N/A 2033-06-21 |
Tarsus Pharmaceuticals Inc. | TARS | Goldberg Andrew D. Director |
8,350 | $0 | 8,350 (Direct) |
View |
| 2023-06-16 Exercise |
2023-06-21 6:18 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Goldberg Andrew D. Director |
2,000 | $0 | 2,000 (Direct) |
View |
| 2022-06-16 Option Award |
2022-07-01 12:21 pm |
N/A 2032-06-15 |
Tarsus Pharmaceuticals Inc. | TARS | Goldberg Andrew D. Director |
9,000 | $0 | 9,000 (Direct) |
View |
| 2021-06-15 Option Award |
2021-06-17 7:21 pm |
N/A 2031-06-15 |
Tarsus Pharmaceuticals Inc. | TARS | Goldberg Andrew D. Director |
17,500 | $0 | 17,500 (Direct) |
View |